Veru Operating Margin from 2010 to 2024
| VERU Stock | USD 0.68 0.05 7.94% |
Check Veru financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Veru's main balance sheet or income statement drivers, such as Depreciation And Amortization of 506 K, Interest Expense of 2.9 M or Total Revenue of 20.2 M, as well as many indicators such as Price To Sales Ratio of 4.01, Dividend Yield of 1.0E-4 or PTB Ratio of 3.39. Veru financial statements analysis is a perfect complement when working with Veru Valuation or Volatility modules.
Veru | Operating Margin |
Latest Veru's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Veru Inc over the last few years. It is Veru's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Veru's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (2.79) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Veru Operating Margin Regression Statistics
| Arithmetic Mean | (1.48) | |
| Coefficient Of Variation | (172.53) | |
| Mean Deviation | 1.98 | |
| Median | (0.20) | |
| Standard Deviation | 2.55 | |
| Sample Variance | 6.49 | |
| Range | 6.9323 | |
| R-Value | (0.80) | |
| Mean Square Error | 2.55 | |
| R-Squared | 0.63 | |
| Significance | 0.0004 | |
| Slope | (0.45) | |
| Total Sum of Squares | 90.85 |
Veru Operating Margin History
About Veru Financial Statements
Veru shareholders use historical fundamental indicators, such as Operating Margin, to determine how well the company is positioned to perform in the future. Although Veru investors may analyze each financial statement separately, they are all interrelated. The changes in Veru's assets and liabilities, for example, are also reflected in the revenues and expenses on on Veru's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida. Veru operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 252 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Veru Stock Analysis
When running Veru's price analysis, check to measure Veru's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veru is operating at the current time. Most of Veru's value examination focuses on studying past and present price action to predict the probability of Veru's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veru's price. Additionally, you may evaluate how the addition of Veru to your portfolios can decrease your overall portfolio volatility.